Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Israeli Equity Fund Approaches Annual Peak on Strong Momentum

Felix Baarz by Felix Baarz
January 17, 2026
in Analysis, Emerging Markets, ETF, Market Commentary
0
iShares MSCI Israel ETF Stock
0
SHARES
11
VIEWS
Share on FacebookShare on Twitter

The iShares MSCI Israel ETF (EIS) is trading near its 52-week high following a substantial rally, fueled by robust domestic equity performance, significant investor inflows, and major technology sector transactions over the past year. The fund’s trajectory raises questions about the sustainability of its current momentum.

Performance and Key Metrics

Recent performance figures underscore the fund’s strength. Over a one-year period, it has delivered gains estimated between 48% and 55%, with a year-to-date increase of 5.7%. As of the latest data, the fund manages approximately $717.6 million in assets and carries an expense ratio of 0.59%.

Liquidity remains consistent, with a 30-day average volume near 93,800 shares and a recent daily volume around 100,200 shares. The fund has also seen substantial net inflows, attracting roughly $308 million over the last twelve months. Its market price has traded at a narrow premium to its net asset value, typically between +0.3% and +0.45%, indicating efficient market pricing.

Portfolio Composition and Sector Exposure

This ETF offers physical exposure to the MSCI Israel Capped Investable Market Index, holding between 110 and 120 individual securities. A notable feature is its high concentration: the top ten holdings account for about 52% of the total portfolio. Major positions include Teva Pharmaceutical, Bank Leumi, Bank Hapoalim, CyberArk, and Elbit Systems. This concentration means the performance of a few key companies can significantly impact the overall fund.

Should investors sell immediately? Or is it worth buying iShares MSCI Israel ETF?

From a sector perspective, financials represent the largest allocation at approximately 32%. Technology is the second-largest sector, comprising nearly 25% of the fund, followed by industrial, healthcare, and real estate companies. This provides a broader exposure to the Israeli economy compared to more narrowly focused technology competitors.

Drivers and Forward-Looking Considerations

Several structural factors could support continued interest. The Tel Aviv Stock Exchange’s shift to a Monday-Friday trading week is expected to improve market accessibility for international investors. Furthermore, significant deals and investments by global corporations into Israel’s cybersecurity and artificial intelligence firms highlight the enduring appeal of its tech sector. The Bank of Israel projects robust GDP growth of around 5.2% for 2026, which may bolster corporate earnings prospects.

However, the strong gains witnessed in 2025 have elevated valuations. The fund’s near-term path is likely tied to the performance of its dominant sectors. A sustained rally in the TA-125 index would likely benefit EIS, while pronounced weakness in technology or financial stocks could place the ETF under considerable pressure. Key indicators to monitor in the coming weeks include the trajectory of the TA-125, continued fund flow data, and fundamental news from the ETF’s largest holdings.

Ad

iShares MSCI Israel ETF Stock: Buy or Sell?! New iShares MSCI Israel ETF Analysis from February 7 delivers the answer:

The latest iShares MSCI Israel ETF figures speak for themselves: Urgent action needed for iShares MSCI Israel ETF investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 7.

iShares MSCI Israel ETF: Buy or sell? Read more here...

Tags: iShares MSCI Israel ETF
Felix Baarz

Felix Baarz

My name is Felix Baarz, and I look back on over fifteen years of experience as a business journalist. I have always been fascinated by the mechanisms and dynamics of global financial markets as well as the complex economic and political interconnections that shape our world. With this passion, I have made a name for myself as an expert on international financial markets and dedicate myself with great commitment to making even the most complex topics understandable and accessible to my readers. My roots lie in Cologne, where I was born and raised. Early on, my curiosity about economic topics and international developments sparked my interest in journalism. After completing my studies, I began my career as a business editor at a respected German trade publication. Here I laid the foundation for my professional career, but my curiosity soon drew me out into the wider world. A turning point in my life was moving to New York, where I lived for six years and gained insight into leading media houses. In this vibrant metropolis, I was able to report firsthand from the heart of the global financial world. From daily developments on Wall Street to major economic policy decisions that make waves worldwide, I had the opportunity to write about central topics that move people and markets alike. This time shaped my perspective and sharpened my view of global interconnections.

Related Posts

Avanos Medical Stock
Analysis

Avanos Medical’s Strategic Pivot: A Focus on High-Margin Growth

February 7, 2026
Guaranty Bancshares Stock
Analysis

Guaranty Bancshares Sees Growth Accelerate Following Texas Expansion

February 7, 2026
ServiceNow Stock
AI & Quantum Computing

ServiceNow Shares Face Market Skepticism Despite Record Performance

February 7, 2026
Next Post
JD.com Stock

Diverging Views Shape the Investment Outlook for JD.com

ADP Stock

ADP's Robust Quarterly Performance and Enhanced Shareholder Returns

Nvidia Stock

Nvidia's AI Ambitions Gain Concrete Validation

Recommended

C3.ai Stock

Is C3.ai Stock Poised for a Rebound?

2 months ago
MMM stock news

Clarification on Hyperlink and Promotional Fees

2 years ago

XOMA Corporation Expands Portfolio with Acquisition of DSUVIA

2 years ago
Microsoft Stock

A Bold Bet: Peter Thiel’s Hedge Fund Doubles Down on Microsoft

1 month ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

ServiceNow Shares Face Market Skepticism Despite Record Performance

Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio

A New Chapter for First Busey as CrossFirst Merger Finalizes

Golden Entertainment to Exit Public Markets in Strategic Privatization Deal

Myers Industries Set to Report Full-Year and Q4 2025 Results

OneSpan Strengthens Mobile Security Arsenal with Strategic Acquisition

Trending

Avanos Medical Stock
Analysis

Avanos Medical’s Strategic Pivot: A Focus on High-Margin Growth

by SiterGedge
February 7, 2026
0

Avanos Medical is navigating a critical strategic transformation. The medical device firm is streamlining its operations to...

Guaranty Bancshares Stock

Guaranty Bancshares Sees Growth Accelerate Following Texas Expansion

February 7, 2026
Yirendai Stock

Yirendai Charts a New Course with Tech-Driven Strategy

February 7, 2026
ServiceNow Stock

ServiceNow Shares Face Market Skepticism Despite Record Performance

February 7, 2026
Orthofix Medical Stock

Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Avanos Medical’s Strategic Pivot: A Focus on High-Margin Growth
  • Guaranty Bancshares Sees Growth Accelerate Following Texas Expansion
  • Yirendai Charts a New Course with Tech-Driven Strategy

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com